DK0739355T3 - Kallikrein-inhiberende "Kunitz-domæne"-proteiner og analoger deraf - Google Patents
Kallikrein-inhiberende "Kunitz-domæne"-proteiner og analoger derafInfo
- Publication number
- DK0739355T3 DK0739355T3 DK95909223T DK95909223T DK0739355T3 DK 0739355 T3 DK0739355 T3 DK 0739355T3 DK 95909223 T DK95909223 T DK 95909223T DK 95909223 T DK95909223 T DK 95909223T DK 0739355 T3 DK0739355 T3 DK 0739355T3
- Authority
- DK
- Denmark
- Prior art keywords
- proteins
- kallikrein
- analogs
- inhibiting
- disclosed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8114—Kunitz type inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17996494A | 1994-01-11 | 1994-01-11 | |
US08/208,264 US6057287A (en) | 1994-01-11 | 1994-03-10 | Kallikrein-binding "Kunitz domain" proteins and analogues thereof |
PCT/US1995/000299 WO1995021601A2 (en) | 1994-01-11 | 1995-01-11 | Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0739355T3 true DK0739355T3 (da) | 2005-01-24 |
Family
ID=26875859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95909223T DK0739355T3 (da) | 1994-01-11 | 1995-01-11 | Kallikrein-inhiberende "Kunitz-domæne"-proteiner og analoger deraf |
Country Status (10)
Country | Link |
---|---|
US (3) | US5795865A (de) |
EP (1) | EP0739355B1 (de) |
JP (1) | JP3805785B2 (de) |
AT (1) | ATE275583T1 (de) |
CA (1) | CA2180950C (de) |
DE (1) | DE69533472T2 (de) |
DK (1) | DK0739355T3 (de) |
ES (1) | ES2227545T3 (de) |
PT (1) | PT739355E (de) |
WO (1) | WO1995021601A2 (de) |
Families Citing this family (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6291662B1 (en) * | 1984-12-05 | 2001-09-18 | Amgen Inc. | Recombinant methods for production of serine protease inhibitors and DNA sequences |
ATE277081T1 (de) | 1994-01-11 | 2004-10-15 | Dyax Corp | Inhibitoren des humanplasmins, die sich von den kunitz domänen ableiten |
US5795865A (en) * | 1994-01-11 | 1998-08-18 | Dyax Corp. | Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof |
US6057287A (en) * | 1994-01-11 | 2000-05-02 | Dyax Corp. | Kallikrein-binding "Kunitz domain" proteins and analogues thereof |
US6010861A (en) * | 1994-08-03 | 2000-01-04 | Dgi Biotechnologies, Llc | Target specific screens and their use for discovering small organic molecular pharmacophores |
ZA963619B (en) | 1995-05-08 | 1996-11-22 | Scios Inc | Protease inhibitor peptides |
US5786328A (en) * | 1995-06-05 | 1998-07-28 | Genentech, Inc. | Use of kunitz type plasma kallikrein inhibitors |
US5780265A (en) * | 1995-06-05 | 1998-07-14 | Genentech, Inc. | Kunitz type plasma kallikrein inhibitors |
US6346510B1 (en) | 1995-10-23 | 2002-02-12 | The Children's Medical Center Corporation | Therapeutic antiangiogenic endostatin compositions |
BR9708021A (pt) * | 1996-03-11 | 1999-07-27 | Bayer Ag | Proteína substancialmente purificada composição farmacêutica sequência de ácido nucleico isolada vetor de express o de protéina auto-replicante e processos para inibir a atividade de protéinas de serina tratar uma condição e preparar um medicamento de uma proteína |
US6946439B2 (en) | 1997-02-06 | 2005-09-20 | Entre Med, Inc. | Compositions and methods for inhibiting cellular proliferation comprising TFPI fragments |
US20060025329A1 (en) * | 1997-02-06 | 2006-02-02 | Todd Hembrough | Compositions and methods for inhibiting cellular proliferation comprising TFPI fragments |
US5981471A (en) | 1997-02-06 | 1999-11-09 | Entremed, Inc. | Compositions and methods for inhibiting cellular proliferation |
JP2001525669A (ja) * | 1997-05-12 | 2001-12-11 | ネーデルランセ オルハニサチエ フォール トゥーヘパスト−ナツールウェーテンシャッペルック オンデルズク テーエヌオー | 細胞遊走の阻害のための方法および構築物 |
DE19725014A1 (de) * | 1997-06-13 | 1998-12-17 | Bayer Ag | Aprotininvarianten mit verbesserten Eigenschaften und Bikunine von Aprotininvarianten |
WO1999061615A1 (en) * | 1998-05-28 | 1999-12-02 | Zymogenetics, Inc. | Kunitz domain polypeptide and materials and methods for making it |
US6087473A (en) * | 1999-05-26 | 2000-07-11 | Zymogenetics, Inc. | Kunitz domain polypeptide and materials and methods for making it |
US6380354B1 (en) | 1998-09-03 | 2002-04-30 | Zymogenetics, Inc. | Kunitz domain polypeptide zkun6 |
US20070140979A1 (en) * | 1998-12-22 | 2007-06-21 | Bayer Aktiengesellschaft | Method for accelerating the rate of mucociliary clearance |
DE69912988T2 (de) * | 1998-12-22 | 2004-11-11 | Bayer Ag | Verwendung eines serinproteaseinhibitors vom kunitz-typ zur beschleunigung der schleimauflöserate |
US6294648B1 (en) * | 1999-07-20 | 2001-09-25 | Bayer Corporation | Protein having proteinase inhibitor activity |
AU2442101A (en) * | 1999-12-22 | 2001-07-03 | Zymogenetics Inc. | Kunitz domain polypeptide zkun11 |
US6544760B2 (en) | 1999-12-22 | 2003-04-08 | Zymogenetics, Inc. | Kunitz domain polypeptide Zkun11 |
AU2296301A (en) * | 1999-12-29 | 2001-07-09 | Zymogenetics Inc. | Kunitz domain polypeptide zkun10 |
US20020004224A1 (en) * | 2000-02-29 | 2002-01-10 | Sheppard Paul O. | Kunitz domain polypeptide zkun8 |
US20030232055A1 (en) * | 2000-07-31 | 2003-12-18 | Ruslan Medzhitov | Innate immune system-directed vaccines |
US20030175287A1 (en) * | 2001-01-03 | 2003-09-18 | Yale University | Innate immune system-directed vaccines |
US20040054082A1 (en) * | 2001-12-03 | 2004-03-18 | Bank David H | Toughened polymer blends with improved surface properties |
JP2005530484A (ja) | 2002-02-07 | 2005-10-13 | デルタ バイオテクノロジー リミテッド | アルブミン融合抗血管形成ペプチド |
US20050222023A1 (en) * | 2002-02-07 | 2005-10-06 | Hans-Peter Hauser | Albumin-fused kunitz domain peptides |
US7153829B2 (en) | 2002-06-07 | 2006-12-26 | Dyax Corp. | Kallikrein-inhibitor therapies |
DK1531791T3 (da) * | 2002-06-07 | 2010-11-01 | Dyax Corp | Forebyggelse og begrænsning af iskæmi |
ES2395014T3 (es) * | 2002-08-28 | 2013-02-07 | Dyax Corp. | Métodos para conservar órganos y tejidos |
DE602004031589D1 (de) * | 2003-01-07 | 2011-04-14 | Dyax Corp | Kunitz-domäne-bibliothek |
US6989369B2 (en) * | 2003-02-07 | 2006-01-24 | Dyax Corp. | Kunitz domain peptides |
BRPI0409557B8 (pt) | 2003-04-04 | 2021-05-25 | Univ Lausanne | proteína recombinante inibidora de calicreína, sequência de dna, vetor de expressão, composição farmacêutica, uso da composição farmacêutica, método de produção da proteína recombinanete e kits de diagnóstico |
EP1663281B1 (de) * | 2003-08-29 | 2013-12-25 | Dyax Corp. | Poly-pegylierte proteasehemmer |
JP4775259B2 (ja) | 2004-03-31 | 2011-09-21 | 味の素株式会社 | アニリン誘導体 |
US7432238B2 (en) * | 2004-04-16 | 2008-10-07 | Stc.Unm | Human Kunitz-type inhibitor with enhanced antifibrinolytic activity |
AU2011218732B2 (en) * | 2004-09-27 | 2013-07-04 | Takeda Pharmaceutical Company Limited | Kallikrein Inhibitors and Uses Thereof |
US7235530B2 (en) | 2004-09-27 | 2007-06-26 | Dyax Corporation | Kallikrein inhibitors and anti-thrombolytic agents and uses thereof |
WO2006057997A2 (en) * | 2004-11-22 | 2006-06-01 | Dyax Corp. | Plasmin-inhibitory therapies |
EP2500031A3 (de) | 2005-02-24 | 2012-12-26 | Joslin Diabetes Center, Inc. | Zusammensetzungen und Verfahren zur Behandlung von Gefäßpermeabilität |
EP1902066A4 (de) * | 2005-07-13 | 2009-01-07 | Amgen Mountain View Inc | Il-6-bindende proteine |
WO2007070372A2 (en) * | 2005-12-09 | 2007-06-21 | Entremed, Inc. | Compositions and methods for inhibiting cellular proliferation |
EP2653542B1 (de) * | 2005-12-29 | 2016-06-29 | The Regents of The University of California | Verfahren und Zusammensetzungen in Verbindung mit mutanter Kunitz-Domäne I von TFPI-2 |
CA2635589C (en) | 2005-12-29 | 2017-01-17 | Dyax Corp. | Protease inhibition |
US7276480B1 (en) | 2005-12-30 | 2007-10-02 | Dyax Corp. | Prevention and reduction of blood loss |
EP2001500A4 (de) * | 2006-03-10 | 2010-07-28 | Dyax Corp | Formulierungen für ecallantid |
AU2007224643B2 (en) * | 2006-03-16 | 2012-10-11 | Takeda Pharmaceutical Company Limited | Compositions and methods using serine protease inhibiting peptides for treating ophthalmic disorders |
EP1854477B9 (de) * | 2006-03-16 | 2018-03-14 | Dyax Corp. | Peptid-Inhibitoren von Plasma Kallikrein zur Verwendung in der Behandlung von Augenerkrankungen |
WO2008077478A1 (en) * | 2006-12-22 | 2008-07-03 | Bayer Schering Pharma Aktiengesellschaft | Preparation and use of variants of the kunitz domain 2 of the human placental bikunin gene |
US20100119512A1 (en) * | 2007-01-25 | 2010-05-13 | Joslin Diabetes Center | Methods of diagnosing, treating, and preventing increased vascular permeability |
CA2696208A1 (en) * | 2007-08-21 | 2009-02-26 | Genzyme Corporation | Treatment with kallikrein inhibitors |
CA2695012A1 (en) * | 2007-08-23 | 2009-02-26 | Genzyme Corporation | Treatment with kallikrein inhibitors |
DE102007056231A1 (de) | 2007-09-08 | 2009-03-12 | Bayer Healthcare Ag | Herstellung und Verwendung von Varianten humander Kunitz-Typ Protease-Inhibitoren (hKTPI) |
WO2010080833A1 (en) | 2009-01-06 | 2010-07-15 | Dyax Corp. | Treatment of mucositis with kallikrein inhibitors |
RS57870B1 (sr) | 2010-01-06 | 2018-12-31 | Dyax Corp | Proteini koji vezuju kalikrein plazme |
KR102107695B1 (ko) | 2011-01-06 | 2020-05-07 | 다이액스 코포레이션 | 혈장 칼리크레인 결합 단백질 |
WO2013172954A1 (en) | 2012-05-17 | 2013-11-21 | Ra Pharmaceuticals, Inc | Peptide and peptidomimetic inhibitors |
PL2946206T3 (pl) | 2013-01-20 | 2019-07-31 | Dyax Corp. | Ocena, testy i leczenie zaburzeń mediowanych przez PKAL |
CA2897336C (en) | 2013-01-20 | 2023-10-17 | Dyax Corp. | Evaluation and treatment of pkal-mediated disorders |
CA2927695C (en) | 2013-10-21 | 2022-03-01 | Dyax Corp. | Diagnosis and treatment of autoimmune diseases |
CN105873951A (zh) | 2013-10-21 | 2016-08-17 | 戴埃克斯有限公司 | 用于确定血浆激肽释放酶系统生物标记的试验 |
EA038532B1 (ru) | 2014-01-21 | 2021-09-10 | Такеда Фармасьютикал Компани Лимитед | Способ лечения наследственного ангионевротического отека (hae) |
BR112016022318A2 (pt) | 2014-03-27 | 2017-10-31 | Dyax Corp | método, composição farmacêutica para uso no tratamento de doenças de retina e uso de um anticorpo |
AU2016243160B2 (en) | 2015-03-30 | 2022-02-24 | Takeda Pharmaceutical Company Limited | Plasma kallikrein inhibitors and uses thereof for preventing hereditary angioedema attack |
WO2017027771A1 (en) | 2015-08-13 | 2017-02-16 | Dyax Corp. | Evacuated blood collection tubes containing protease inhibitors for the assessment of contact system activation |
PL3365685T3 (pl) | 2015-10-19 | 2021-08-02 | Dyax Corp. | Test immunologiczny do wykrywania rozszczepionego wielkocząsteczkowego kininogenu |
BR112018011622A2 (pt) | 2015-12-11 | 2018-11-27 | Dyax Corp | método para tratar ataque de angioedema hereditário (hae) ou reduzir a taxa de ataque de hae |
KR102464380B1 (ko) | 2016-09-16 | 2022-11-07 | 다케다 파머수티컬 컴패니 리미티드 | 접촉 활성화 시스템과 연관된 질환을 위한 대사물질 바이오마커 |
KR20230125104A (ko) | 2016-09-16 | 2023-08-28 | 다케다 파머수티컬 컴패니 리미티드 | 유전성 혈관부종에 대한 rna 바이오마커 |
AU2017325983B2 (en) | 2016-09-16 | 2023-12-07 | Takeda Pharmaceutical Company Limited | Protein biomarkers for diseases associated with the contact activation system |
HUP1700012A2 (en) | 2017-01-06 | 2018-07-30 | Evolveritas Kft | Novel proteins and use thereof |
AU2019328324A1 (en) | 2018-08-30 | 2021-04-29 | Takeda Pharmaceutical Company Limited | Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack |
KR20210142006A (ko) | 2019-03-14 | 2021-11-23 | 다케다 파머수티컬 컴패니 리미티드 | 유전성 혈관부종 발작의 치료를 위한 혈장 칼리크레인 저해제 및 이의 용도 |
WO2021146160A1 (en) | 2020-01-13 | 2021-07-22 | Takeda Pharmaceutical Company Limited | Plasma kallikrein inhibitors and uses thereof for treating pediatric hereditary angioedema attack |
WO2021198534A1 (en) | 2020-04-04 | 2021-10-07 | Oxurion NV | Plasma kallikrein inhibitors for use in the treatment of coronaviral disease |
EP4126219A2 (de) | 2020-04-04 | 2023-02-08 | Takeda Pharmaceutical Company Limited | Plasmakallikreinhemmer und verwendungen davon zur behandlung von akutem atemnotsyndrom |
WO2023144030A1 (en) | 2022-01-31 | 2023-08-03 | Oxurion NV | Plasma kallikrein inhibitor therapy for anti-vegf sensitization |
WO2023148016A1 (en) | 2022-02-04 | 2023-08-10 | Oxurion NV | Biomarker for plasma kallikrein inhibitor therapy response |
WO2024003617A2 (en) | 2022-06-30 | 2024-01-04 | Takeda Pharmaceutical Company Limited | Protein biomarkers for lanadelumab treatment |
WO2024069200A2 (en) | 2022-09-29 | 2024-04-04 | Evolveritas Biotechnológiai Korlátolt Felelősségű Társaság | A modified protein scaffold and use thereof |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3691016A (en) * | 1970-04-17 | 1972-09-12 | Monsanto Co | Process for the preparation of insoluble enzymes |
CA1023287A (en) * | 1972-12-08 | 1977-12-27 | Boehringer Mannheim G.M.B.H. | Process for the preparation of carrier-bound proteins |
US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
DE2619246A1 (de) * | 1976-04-30 | 1977-11-10 | Bayer Ag | Desamino-derivate des kallikrein- trypsin-inhibitors, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
US4195128A (en) * | 1976-05-03 | 1980-03-25 | Bayer Aktiengesellschaft | Polymeric carrier bound ligands |
DE2654124A1 (de) * | 1976-11-29 | 1978-06-01 | Bayer Ag | Derivate des trypsin-kallikrein-inhibitors aus rinderorganen (bpti) mit proteasenhemmwirkung und antiphlogistischer wirkung, ihre herstellung und ihre verwendung als arzneimittel |
US4330440A (en) * | 1977-02-08 | 1982-05-18 | Development Finance Corporation Of New Zealand | Activated matrix and method of activation |
CA1093991A (en) * | 1977-02-17 | 1981-01-20 | Hideo Hirohara | Enzyme immobilization with pullulan gel |
US4229537A (en) * | 1978-02-09 | 1980-10-21 | New York University | Preparation of trichloro-s-triazine activated supports for coupling ligands |
US4609725A (en) * | 1984-10-09 | 1986-09-02 | Merck & Co., Inc. | Cardiac atrial peptides |
EP0285123A3 (de) * | 1987-04-03 | 1989-02-01 | Stabra AG | Verfahren zur vollständigen Mutagenese von Nucleinsäuren |
US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
IL104325A (en) * | 1992-01-07 | 2000-10-31 | Novo Nordisk As | Variants of human kunitz-type protease inhibitor domain II of tissue factor pathway inhibitor (TFPI) pharmaceutical compositions containing them a DNA construct encoding them their expression vectors a cell containing said DNA constructs and methods for the production of all the above |
IL104326A0 (en) * | 1992-01-07 | 1993-05-13 | Novo Nordisk As | Variant of human kunitz-type protease inhibitor |
IL104324A0 (en) * | 1992-01-07 | 1993-05-13 | Novo Nordisk As | Variant of human kunitz-type protease inhibitor |
US5795865A (en) * | 1994-01-11 | 1998-08-18 | Dyax Corp. | Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof |
-
1995
- 1995-01-11 US US08/676,125 patent/US5795865A/en not_active Expired - Lifetime
- 1995-01-11 EP EP95909223A patent/EP0739355B1/de not_active Expired - Lifetime
- 1995-01-11 WO PCT/US1995/000299 patent/WO1995021601A2/en active IP Right Grant
- 1995-01-11 DK DK95909223T patent/DK0739355T3/da active
- 1995-01-11 PT PT95909223T patent/PT739355E/pt unknown
- 1995-01-11 ES ES95909223T patent/ES2227545T3/es not_active Expired - Lifetime
- 1995-01-11 DE DE69533472T patent/DE69533472T2/de not_active Expired - Lifetime
- 1995-01-11 AT AT95909223T patent/ATE275583T1/de active
- 1995-01-11 JP JP51872695A patent/JP3805785B2/ja not_active Expired - Lifetime
- 1995-01-11 CA CA002180950A patent/CA2180950C/en not_active Expired - Lifetime
-
1998
- 1998-08-17 US US09/136,012 patent/US5994125A/en not_active Expired - Lifetime
-
1999
- 1999-10-19 US US09/421,097 patent/US6333402B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES2227545T3 (es) | 2005-04-01 |
EP0739355A1 (de) | 1996-10-30 |
PT739355E (pt) | 2005-01-31 |
US5795865A (en) | 1998-08-18 |
US6333402B1 (en) | 2001-12-25 |
CA2180950C (en) | 2005-03-29 |
DE69533472T2 (de) | 2006-01-12 |
CA2180950A1 (en) | 1995-08-17 |
WO1995021601A2 (en) | 1995-08-17 |
DE69533472D1 (de) | 2004-10-14 |
EP0739355B1 (de) | 2004-09-08 |
US5994125A (en) | 1999-11-30 |
JPH09511131A (ja) | 1997-11-11 |
JP3805785B2 (ja) | 2006-08-09 |
WO1995021601A3 (en) | 1995-09-21 |
ATE275583T1 (de) | 2004-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0739355T3 (da) | Kallikrein-inhiberende "Kunitz-domæne"-proteiner og analoger deraf | |
WO1995018830A3 (en) | Inhibitors of human plasmin derived from the kunitz domains | |
EP1484339A3 (de) | Kallikreinhemmende "Kunitz-Domäne"Proteine dafür kodierende Nukleinsäure | |
DK0535091T3 (da) | Knogleinducerende farmaceutiske formuleringer | |
DE69625691T2 (de) | Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten | |
FI880464A0 (fi) | Bekaempningsmedel mot tandplaque och -karies. | |
NO965098L (no) | Perfluoralkylketoninhibitorer av elastase og fremgangsmåter for fremstilling av disse | |
NO983294L (no) | Bowman-Birk inhibitor for hankj°nn dysfunksjon | |
DE69626671D1 (de) | Fusionsproteine bestehend aus gewebefaktor-kunitzdomäne als inhibitoren des faktors viia | |
ES2167364T3 (es) | Inhibidores de trombina. | |
EE200000163A (et) | Protsess kirurgiliste instrumentide puhastamiseks | |
ATE401337T1 (de) | Antiangiogene polypeptide | |
EP0326013A3 (de) | Von menschlichem alpha-2-Plasmin-Inhibitor abgeleitete neue Proteine oder Proteine, die diesen ähnlich sind | |
DK0828483T3 (da) | Anvendelse af tropolonderivater som inhibitorer af enzymet inositolmonophosphatase | |
UA9703A (uk) | Антипротеіназний засіб | |
MY118194A (en) | Pharmaceutical compositions for use in inhibiting bone resorption | |
GEP19991605B (en) | Inhibitor, Its Obtaining and Use |